Live Breaking News & Updates on வெளிப்படையான ஸ்பாரசினோ

Stay updated with breaking news from வெளிப்படையான ஸ்பாரசினோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference


MOORESTOWN, N.J., Dec. 29, 2020 (GLOBE NEWSWIRE)
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin Boesen; and Chief Financial Officer, Brian W. Adams, will participate in the 39
th Annual J.P. Morgan Healthcare Conference to be held virtually January 11-14, 2021.
The TRHC presentation is scheduled for Thursday, January 14, 2021 at 4:30 p.m. EST. An audio replay of the presentation will be available at https://ir.tabularasahealthcare.com/.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides patient medication safety solutions empowering pharmacists and prescribers to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise ....

Kevin Boesen , Brianw Adams , Orsulav Knowlton , Dianne Semingson , Frank Sparacino , Tabula Rasa Healthcare Inc , Corporate Development , Business Development , Rasa Healthcare , Chief Marketing , Business Development Officer , Chief Sales Officer , Chief Financial Officer , Healthcare Conference , Rasa Healthcare Investor Relations Contact , Vice President , Investor Relations , Rasa Healthcare Media Contact , கெவின் போஸன் , டயான் செமிங்சோங் , வெளிப்படையான ஸ்பாரசினோ , அட்டவணை ராசா சுகாதாரம் இன்க் , பெருநிறுவன வளர்ச்சி , வணிக வளர்ச்சி , ராசா சுகாதாரம் , தலைமை சந்தைப்படுத்தல் ,

Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare's DoseMeRx Integration


Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration
Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration
Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx„¢, a Tabula Rasa Healthcare precision dosing solution, with Sentri7s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times.
Dosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient, said Charles Cornish, Executive Vice President, Hospitals Business Unit, TRHC. By integrating our precision dosing platform with Wolters Kluwers Sent ....

United States , Karen Kobelski , Wolters Kluwer , Dianne Semingson , Charles Cornish , Frank Sparacino , Wolters Kluwers Sentri , Compliance Data Solutions At Wolters Kluwer , American Society Of Health System Pharmacists , Tabula Rasa Healthcare , Antimicrobial Stewardship , Executive Vice President , Hospitals Business Unit , American Society , Health System Pharmacists , Vice President , General Manager , Clinical Surveillance , Data Solutions , Core Elements , Rasa Healthcare , ஒன்றுபட்டது மாநிலங்களில் , வால்டர்ஸ் க்லூவர் , டயான் செமிங்சோங் , சார்லஸ் கார்னிஷ் , வெளிப்படையான ஸ்பாரசினோ ,